DM
ANIP icon

Deerfield Management’s ANI Pharmaceuticals ANIP Stock Holding History

Deerfield Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,138
Closed -$327K – 456
2024
Q2 		$327K Buy
5,138
+511
+11% +$33.2K 0.01% 327
2024
Q1 		$320K Sell
4,627
-1,720
-27% -$104K 0.01% 241
2023
Q4 		$350K Buy
+6,347
New +$350K 0.01% 102
2014
Q4 		– Sell
-607,355
Closed -$17.2M – 115
2014
Q3 		$17.2M Hold
607,355
– – 0.7% 51
2014
Q2 		$20.9M Buy
607,355
+235,783
+63% +$7.39M 0.93% 42
2014
Q1 		$11.6M Buy
+371,572
New +$9.86M 0.53% 58

Other funds holding ANIP

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $34.9B AUM 18.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return